IRIS
DAVI', Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.551
EU - Europa 8.566
AS - Asia 8.510
SA - Sud America 1.498
AF - Africa 110
Continente sconosciuto - Info sul continente non disponibili 32
OC - Oceania 5
Totale 30.272
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.342
SG - Singapore 3.170
CN - Cina 2.715
UA - Ucraina 1.869
IE - Irlanda 1.540
TR - Turchia 1.416
BR - Brasile 1.249
SE - Svezia 987
GB - Regno Unito 930
IT - Italia 797
DE - Germania 738
FR - Francia 677
VN - Vietnam 438
FI - Finlandia 427
IN - India 370
RU - Federazione Russa 325
CA - Canada 109
AR - Argentina 108
PL - Polonia 72
MX - Messico 66
HK - Hong Kong 65
EC - Ecuador 54
ZA - Sudafrica 50
BD - Bangladesh 48
AT - Austria 39
CZ - Repubblica Ceca 39
KR - Corea 38
IQ - Iraq 37
ID - Indonesia 35
JP - Giappone 35
ES - Italia 33
EU - Europa 26
CO - Colombia 20
MA - Marocco 20
PK - Pakistan 20
IL - Israele 19
NL - Olanda 18
VE - Venezuela 18
BE - Belgio 15
PY - Paraguay 14
CL - Cile 13
IR - Iran 13
LT - Lituania 13
UZ - Uzbekistan 13
AE - Emirati Arabi Uniti 11
EG - Egitto 10
PE - Perù 9
RO - Romania 9
SA - Arabia Saudita 9
UY - Uruguay 9
AZ - Azerbaigian 8
TN - Tunisia 8
AL - Albania 7
HN - Honduras 7
BG - Bulgaria 6
DZ - Algeria 6
KE - Kenya 6
KZ - Kazakistan 6
TW - Taiwan 6
CR - Costa Rica 5
OM - Oman 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BZ - Belize 4
JO - Giordania 4
LB - Libano 4
TT - Trinidad e Tobago 4
AU - Australia 3
BO - Bolivia 3
CH - Svizzera 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
KG - Kirghizistan 3
MY - Malesia 3
NG - Nigeria 3
NI - Nicaragua 3
QA - Qatar 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
BH - Bahrain 2
BN - Brunei Darussalam 2
EE - Estonia 2
GR - Grecia 2
JM - Giamaica 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
SI - Slovenia 2
SV - El Salvador 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BW - Botswana 1
BY - Bielorussia 1
ET - Etiopia 1
GA - Gabon 1
HU - Ungheria 1
KH - Cambogia 1
Totale 30.258
Salva come PNG Salva come JPEG
Città #
Singapore 2.435
Jacksonville 2.154
Dublin 1.531
Chandler 1.452
Princeton 744
Izmir 731
Southend 656
Dallas 651
Nanjing 603
Beijing 600
Ashburn 574
Wilmington 383
Cambridge 340
Santa Clara 337
Los Angeles 324
Dearborn 298
Altamura 295
Nanchang 224
Tongling 210
Buffalo 184
New York 175
Ho Chi Minh City 169
The Dalles 167
Ann Arbor 164
Munich 140
São Paulo 130
Chieti 127
Boardman 111
Hebei 103
Shenyang 103
Woodbridge 101
Tianjin 91
Kunming 88
Hanoi 85
Moscow 70
Washington 70
Jiaxing 69
Grevenbroich 67
Hong Kong 63
Helsinki 60
Norwalk 56
Changsha 54
Redondo Beach 54
Warsaw 49
Montreal 46
Brooklyn 40
Seoul 37
Council Bluffs 36
Hangzhou 35
Johannesburg 35
Augusta 33
Tokyo 33
Turku 33
Houston 32
Orange 31
Chennai 30
Denver 30
Seattle 29
Toronto 29
Brno 28
Jinan 28
Rio de Janeiro 28
Changchun 27
Lanzhou 27
Poplar 27
Stockholm 27
Hefei 25
San Mateo 25
Chicago 24
London 23
Atlanta 22
Boston 22
Brasília 22
Haiphong 22
Ningbo 22
Rome 22
San Francisco 22
Belo Horizonte 21
Guayaquil 21
Curitiba 19
Falls Church 19
Pescara 19
Shanghai 19
Frankfurt am Main 18
Leawood 18
Mexico City 18
Orem 18
Phoenix 18
Nuremberg 17
Quito 17
Baghdad 16
Da Nang 16
Mumbai 16
Brussels 15
Guarulhos 15
Biên Hòa 14
Ribeirão Preto 14
Sorocaba 14
Zhengzhou 14
Guangzhou 12
Totale 18.432
Salva come PNG Salva come JPEG
Nome #
ASSOCIATION OF LEPTIN, ENDOTHELIAL PERTURBATION AND COAGULATIVE ACTIVATION IN OBESE HEALTHY WOMEN (XVI National Congress of the Italian Society for the study of Arteriosclerosis - Chieti, 27-30 novembre 2002) 167
Vitamin E supplementation normalizes LDL susceptibility to oxidation in well controlled uncomplicated type II diabetes mellitus 166
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 157
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 157
Pentraxin 3 and platelet activation in obese patients after gastric banding 155
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 150
Il trattamento con Metformina riduce i livelli di alcuni indicatori di stress ossidativi in diabetici di tipo 2 142
MicroRNA-181b regulates ALX/FPR2 expression and proresolution signaling in human macrophages. 141
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 140
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes. 138
Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation 136
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 136
Determinants of platelet activation in hypertensives with microalbuminuria. 135
A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction 135
Oxidative-induced membrane damage in diabetes lymphocytes: effects on intracellular Ca2+ homeostasis 134
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 133
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: Impact on mediators and mechanisms of the inflammatory response 133
5-Lipoxygenase regulates malignant mesothelial cellsurvival: involvement of vascular endothelialgrowth factor 128
Association of Inflammation Markers with ImpairedInsulin Sensitivity and Coagulative Activation inObese Healthy Women 126
In vivo platelet activation is responsible for enhanced vascular endothelial growth factor levels in hypertensive patients. 126
Platelets and Diabetes 126
Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation 126
Association of low-grade inflammation and platelet activation in hypertensive patients with microalbuminuria 125
Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost. 125
Association of serum bilirubin with oxidant damage of human atherosclerotic plaques and the severity of atherosclerosis 125
Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss. 125
The Recovery of Platelet Cyclooxygenase Activity Explains Interindividual Variability in Responsiveness to Low-Dose Aspirin in Patients With and Without Diabetes. 125
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 124
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin 122
Thromboxane biosynthesis and pulmonary function in cystic fibrosis 121
Increased soluble CD40L levels in cystic fibrosis 120
Circulating endothelial progenitor cells and low-dose-aspirin-insensitive thromboxane biosynthesis in polycythemia rubra vera. 120
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 120
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. 120
Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes 120
Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels 119
Livelli circolanti di adiponectina e interleuchina-10 nell’obesità di tipo androide. 119
Arterial stiffness and sedentary lifestyle: Role of oxidative stress 119
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 118
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. 118
Platelets and diabetes mellitus 117
Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease 117
Vitamin E inhibits enhanced F2 isoprostane biosynthesis in type IIA hypercholesterolemia 115
Determinants of the Variability in the Recovery Rate of Platelet Cyclooxygenase Activity during Chronic Therapy with Low-Dose Aspirin in Type 2 Diabetes 115
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. 115
Coagulation and infective endocarditis: sooner or later 115
Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetes subjects 114
CD40 ligand and MCP-1 as predictors of cardiovascular events in diabetic patients with stroke. 114
Endogenous Secretory RAGE in Obese Women: Association with Platelet Activation and Oxidative Stress 114
Endothelial Perturbation in Children andAdolescents With Type 1 Diabetes: association with markers of the inflammatory reaction 114
Leptin increase is associated with markers of the hemostatic system in obese healthy women 113
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 113
Under-detection of delirium and impact of neurocognitive deficits on in-hospital mortality among acute geriatric and medical wards 113
Physical exercise increases urinary excretion of lipoxin A4 and related compounds 112
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 112
Insulin resistance as a determinant of platelet activation in obese women. 112
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 112
The relationship between clinical events and JAK2V617F mutation status in a cohort of 75 patients with essential thrombocythemia 110
Oxidative stress drivers and modulators in obesity and cardiovascular disease: from biomarkers to therapeutic approach. 110
[The "problem obesity": viewpoint of the internist] 110
Effects of high-amount-high-intensity exercise on in vivo platelet activation: Modulation by lipid peroxidation and AGE/RAGE axis 110
Determinants of increased cardiovascular disease in obesity and metabolic syndrome. 110
A comparison of five maintenance therapies for reflux esophagitis 109
Platelet activation in obesity and metabolic syndrome. 109
[The "problem obesity": viewpoint of the internist]. 109
Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus. 108
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. 108
Aspirin, platelets, and cancer: The point of view of the internist. 108
Urinary excretion of lipoxin A4 and related compounds: Development of new extraction techniques for lipoxins 108
Soluble forms of RAGE in human diseases: clinical and therapeutical implications. 107
Antipsychotic prescription and mortality in hospitalized older persons 107
Enhanced soluble CD40 Ligand is responsible for endothelial dysfunction and monocyte activation in patients with diabetes mellitus. Effect of improved metabolic control. 106
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. 106
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 106
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 106
The deadly line linking sympathetic overdrive, dipping status and vascular risk: Critical appraisal and therapeutic implications 106
Association between serum leptin levels and 24-hour blood pressure in obese women. 106
Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. 105
Homocysteine modulates the CD40/CD40L system 105
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. 105
Circulating MRP 8/14 is Associated with Thromboxane Dependent Platelet Activation in NSTEMI Patients: Effect of Aspirin Treatment 105
Mean platelet volume variation after biologic therapy in psoriasis and psoriatic arthritis. 105
Circulating Myeloid-Related Protein-8/14 is Related to Thromboxane-Dependent Platelet Activation in Patients With Acute Coronary Syndrome, With and Without Ongoing Low-Dose Aspirin Treatment. 104
Soluble forms of RAGE in internal medicine. 104
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 103
The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy 103
Atherothrombotic disease and the metabolic syndrome. 102
Determinants of platelet activation in hypertensives with microalbuminuria. 102
LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro 102
Use of non-steroidal anti-inflammatory drugs and analgesics in a cohort of hospitalized elderly patients: Results from the REPOSI study 102
Defining Aging Phenotypes and Related Outcomes: Clues to Recognize Frailty in Hospitalized Older Patients 102
Soluble RAGE in type 2 diabetes: association with oxidative stress. 101
Antiplatelet Agents. Thromboxane receptors antagonists and/or synthase inhibitors 100
Diabetes mellitus and thrombosis 100
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation. (pubbl su Suppl Thromb Haemostas) 99
Endothelial dysfunction and oxidative stress in arterial hypertension. 99
Thromboxane-dependent CD40L release in type 2 diabetes mellitus 99
[Analysis of various blood coagulation indices in a group of hypertensive, arteriosclerotic and dyslipidemic patients with post-prandial hypertriglyceridemia]. 98
Association between PAI-1 and Oxidative Stress in Android Obesity 98
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 98
Totale 11.709
Salva come PNG Salva come JPEG
Categoria #
all - tutte 129.677
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 129.677
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.135 0 0 0 0 0 487 24 20 157 326 39 82
2021/20221.396 23 29 11 218 104 20 22 121 121 53 216 458
2022/20234.428 432 654 236 425 385 931 302 299 529 45 97 93
2023/20241.949 139 78 136 50 118 633 504 72 18 33 14 154
2024/20255.400 463 1.089 862 67 77 134 82 223 519 207 566 1.111
2025/20265.731 911 482 1.396 1.875 951 116 0 0 0 0 0 0
Totale 31.369